Films from 'How has Cambridge become the Capital of UK Life Sciences' - 17 January
With 431 companies, employing over 13,000 people and a list of world leading companies and institutions based in the city, Cambridge has become the leading site for life sciences in the UK. How did this happen, what makes the city different and how will the future look?
To answer these questions and more, we brought together the people and organisations who are leading the way through research, clinical excellence and commercial prowess.
Below are talks from Sir Hugh Pelham, Director, the MRC Laboratory of Molecular Biology, Andy Williams, Vice President, Cambridge Strategy and Operations, AstraZeneca and Alan Hirzel, Chief Executive Officer, Abcam as well as a panel discussion with: Chair Professor Patrick Maxwell – Regius Professor of Physic and Head of School of Clinical Medicine, University of Cambridge, Kathryn Chapman – Executive Manager, Milner Therapeutics Institute, Antonio Criminisi – Principal Researcher, Microsoft Research Cambridge, Professor Richard Gilbertson – Li Ka Shing Chair of Oncology, Director, Cancer Research UK Cambridge Centre, Victoria Higgins – Senior Director, University of Cambridge-GSK Strategic Alliance, Jon Freeman – Research Group Director, Innovation, Health and Science, RAND Europe and Andy Williams – Vice President, Cambridge Strategy and Operations, AstraZeneca.